Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | NAD(P)H dehydrogenase, quinone 2 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 19, subfamily A, polypeptide 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450, putative | cytochrome P450, family 19, subfamily A, polypeptide 1 | 503 aa | 425 aa | 18.8 % |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | NAD(P)H dehydrogenase, quinone 2 | 231 aa | 213 aa | 26.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 1 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in A-549 lung carcinoma cell lines | ChEMBL. | 1875350 |
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in MCF-7 breast carcinoma cell lines | ChEMBL. | 1875350 |
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in HT-29 colon adenocarcinoma cell lines | ChEMBL. | 1875350 |
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in SKMEL-5 melanoma cell lines | ChEMBL. | 1875350 |
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in MLM melanoma cell lines | ChEMBL. | 1875350 |
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in A-549 lung carcinoma cell lines | ChEMBL. | 1875350 |
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in MCF-7 breast carcinoma cell lines | ChEMBL. | 1875350 |
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in HT-29 colon adenocarcinoma cell lines | ChEMBL. | 1875350 |
ED50 (functional) | > 25 uM | Cytotoxic concentration required to inhibit 50% cell growth in SKMEL-5 melanoma cell lines | ChEMBL. | 1875350 |
IC50 (binding) | = 0.27 uM | Inhibition of human quinone reductase 2 expressed in Escherichia coli BL21(DE3) by UV-vis microplate reader analysis | ChEMBL. | 20558073 |
IC50 (binding) | = 0.9 uM | Inhibition of human aromatase preincubated with NADP+ for 10 mins before substrate addition measured after 30 mins | ChEMBL. | 20558073 |
Inhibition (binding) | = 90.86 % | Inhibition of human aromatase at 20 ug/ml preincubated with NADP+ for 10 mins before substrate addition measured after 30 mins | ChEMBL. | 20558073 |
Km (binding) | = 6.25 uM | Inhibition of human aromatase at IC50 concentration preincubated with NADP+ for 10 mins before substrate addition measured after 30 mins | ChEMBL. | 20558073 |
Vmax (binding) | = 35.4 pmol/min | Inhibition of human aromatase assessed per mg of protein at IC50 concentration preincubated with NADP+ for 10 mins before substrate addition measured after 30 mins | ChEMBL. | 20558073 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.